Earnings History Data for ClearPoint Neuro Inc. (CLPT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ClearPoint Neuro Inc.

ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-08-2022	AH	4:05 PM ET (Aug 9)	CLPT	ClearPoint Neuro Inc.	213.63	-0.18	-0.18	-0.17	ClearPoint Neuro GAAP EPS of -$0.18 in-line, revenue of $5.2M beats by $0.12M [8/9/2022 4:30 PM]	16.49	1.97 (13.57%)	15.20	0.68 (4.68%)	7.00 - 22.31	380,020	120,000	1,069
ClearPoint Neuro GAAP EPS of -$0.18 in-line, revenue of $5.2M beats by $0.12M [8/9/2022 4:30 PM] FDA approves ClearPoint Neuro's brain imaging and modelling medical device [8/9/2022 4:37 PM] ClearPoint Neuro Reports Second Quarter 2022 Results [Aug-09-22 04:15PM] ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro Brain Model [Aug-09-22 04:05PM] ClearPoint Neuro, Inc. Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs [Aug-08-22 04:05PM]
11-05-2022	AH	4:05 PM ET (May 11)	CLPT	ClearPoint Neuro Inc.	116.10	-0.17	0.00	-0.13	ClearPoint Neuro GAAP EPS of -$0.17 beats by $0.03, revenue of $5.03M beats by $0.85M [5/11/2022 4:09 PM]	7.75	0.66 (9.31%)	7.81	0.72 (10.16%)	7.00 - 22.80	605,649	250,000	4,713
ClearPoint Neuro GAAP EPS of -$0.17 beats by $0.03, revenue of $5.03M beats by $0.85M [5/11/2022 4:09 PM] ClearPoint Neuro stock rises 18% after Q1 show boosts FY22 revenue outlook [5/12/2022 11:06 AM] ClearPoint Neuro Reports First Quarter 2022 Results [May-11-22 04:05PM]
01-03-2022	AH	4:05 PM ET (Mar 1)	CLPT	ClearPoint Neuro Inc.	136.39	-0.19	0.00	-0.09	ClearPoint Neuro GAAP EPS of -$0.69 misses by $0.01, revenue of $16.3M in-line [3/1/2022 4:30 PM]	8.74	0.21 (2.40%)	9.30	0.76 (8.90%)	7.47 - 24.59	155,303	210,000	1,539
ClearPoint Neuro GAAP EPS of -$0.69 misses by $0.01, revenue of $16.3M in-line [3/1/2022 4:30 PM] ClearPoint Neuro Reports Fourth Quarter and Full-Year 2021 Results [Mar-01-22 04:07PM]
09-11-2021	AH	4:05 PM ET (Nov 9)	CLPT	ClearPoint Neuro Inc.	296.69	-0.18	0.00	-0.09	ClearPoint Neuro EPS misses by $0.02, beats on revenue [11/9/2021 4:25 PM]	16.98	-0.26 (-1.52%)	18.17	0.93 (5.39%)	6.85 - 31.29	404,234	210,000	2,372
ClearPoint Neuro EPS misses by $0.02, beats on revenue [11/9/2021 4:25 PM] Warning: CLPT is at high risk of performing badly [11/10/2021 4:51 AM] ClearPoint Neuro Congratulates Neurona Therapeutics on IND Clearance for Neural Cell Therapy NRTX-1001 in Chronic Focal Epilepsy Patients [Nov-08-21 04:05PM] ClearPoint Neuro Reports Third Quarter 2021 Results [Nov-09-21 04:05PM]
10-08-2021	AH	4:05 PM ET (Aug 10)	CLPT	ClearPoint Neuro Inc.	350.02	-0.17	-0.14	-0.11	ClearPoint Neuro EPS misses by $0.03, misses on revenue [8/10/2021 4:13 PM]	18.24	-3.65 (-16.67%)	20.55	-1.34 (-6.12%)	3.48 - 31.29	1,313,318	310,000	2,341
ClearPoint Neuro EPS misses by $0.03, misses on revenue [8/10/2021 4:13 PM] ClearPoint Neuro, Inc. Announces Strategic and Commercial Partnership with European Surgical Equipment Leader adeor medical AG [Aug-09-21 08:00AM] ClearPoint Neuro Reports Second Quarter 2021 Results [Aug-10-21 04:05PM]
11-05-2021	AH	4:05 PM ET (May 11)	CLPT	ClearPoint Neuro Inc.	297.95	-0.13	-0.15	-0.13	ClearPoint Neuro EPS beats by $0.01, beats on revenue [5/11/2021 4:06 PM]	17.85	0.19 (1.08%)	18.90	1.24 (7.02%)	2.90 - 31.29	432,890	280,000	4,472
ClearPoint Neuro EPS beats by $0.01, beats on revenue [5/11/2021 4:06 PM] ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and Operating Room [May-10-21 05:21PM] Clearpoint Neuro, Inc. to Host Earnings Call [May-11-21 02:30PM] ClearPoint Neuro Reports Record Revenue in First Quarter 2021 Results, Announces FDA Clearance of the SmartFrame Array [May-11-21 04:05PM]
04-03-2021	AH	4:05 PM ET (Mar 4)	CLPT	ClearPoint Neuro Inc.	373.15	-0.09	-0.13	-0.11	ClearPoint Neuro EPS misses by $0.01, beats on revenue [3/4/2021 4:34 PM]	17.55	-2.52 (-12.56%)	20.49	0.42 (2.09%)	2.86 - 31.29	2,310,936	785,662	3,325
ClearPoint Neuro EPS misses by $0.01, beats on revenue [3/4/2021 4:34 PM]
10-11-2020	AH		CLPT	ClearPoint Neuro Inc.	104.46	-0.09	-0.14	-0.08	ClearPoint Neuro EPS beats by $0.06, beats on revenue [11/10/2020 4:07 PM]	8.00	1.15 (16.79%)	8.00	1.15 (16.79%)	2.86 - 8.91	539,670	94,598	26,626

12-08-2020	AH	4:05 PM ET (Aug 12)	CLPT	ClearPoint Neuro Inc.	63.90	-0.11	-0.16	-0.13	ClearPoint Neuro EPS beats by $0.03, beats on revenue [8/12/2020 4:09 PM]	4.28	0.28 (7.00%)	4.06	0.06 (1.50%)	2.86 - 6.33	73,763	35,188	349

12-05-2020	AH		CLPT	ClearPoint Neuro Inc.	56.27	-0.13	-0.18	-0.11	ClearPoint Neuro EPS beats by $0.05, misses on revenue [5/12/2020 4:13 PM]	3.17	-0.33 (-9.43%)	3.20	3.20 (0.00%)	2.86 - 6.33	231,896	21,480	6,857